Gene · 23543
RBFOX2: RNA binding fox-1 homolog 2
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. RBFOX2: RNA binding fox-1 homolog 2. Genes, record 23543. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/23543
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O43251 | RNA binding protein fox-1 homolog 2 | 390 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents0
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
None in this release.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,932
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | RBFOX2 papers | Newest fiscal year |
|---|---|---|---|
| P01CA019014 | Viral Oncogenesis, Latency, and Replication | 11 | 2025 |
| R01CA096512 | Cell model for KSHV infection and genetic manipulation | 11 | 2025 |
| R01CA117830 | Epigenomic Control of KSHV Latency | 10 | 2025 |
| R01CA124332 | Regulation of KSHV replication by N6-methyladenosine (m6A) | 10 | 2025 |
| P30CA016520 | Abramson Cancer Center Support Grant | 9 | 2025 |
| R01GM085319 | Function of Sequence-specific RNA Binding Proteins | 9 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 8 | 2025 |
| P30CA010815 | Consolidated Basic Cancer Research Program | 8 | 2025 |
| P01CA022443 | Molecular Biology and Genetics of Human Tumor Viruses | 7 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 7 | 2025 |
1 to 10 of 1,932Source NIH's project files
See all 1,932 nih grantsPapers2,101
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CYTOKINE SIGNALING REGULATES MULTIPLE STAGES OF GAMMA-HERPESVIRUS INFECTION IN MYELOID CELLS. | bioRxiv | 2026 | 42818232 | PubTator, text mining | PubMed |
| Pan-cancer splicing landscape identifies that the alternative splicing of SLK regulates cancer metastasis. | Pharmacol Res | 2026 | 42674125 | PubTator, text mining | PubMed |
| Functional validation of driver mutation-specific uveal melanoma biomarkers: role of COL9A3 in cancer cell plasticity. | J Pathol | 2026 | 42482451 | PubTator, text mining | PubMed |
| RBFOX2 suppresses NETosis and glioma growth via 5hmC-dependent PDGFB decay. | Cell Rep | 2026 | 42284147 | PubTator, text mining | PubMed |
| The RNA-binding protein RBFOX2 suppresses colorectal cancer proliferation and metastasis by reducing FUBP1 mRNA stability to induce mitochondrial dysfunction and ferroptosis. | Discov Oncol | 2026 | 42223720 | PubTator, text mining | PubMed |
| Systematic analysis of hippo pathway signaling identifies TEAD1 as a transcriptional regulator of neuroendocrine prostate cancer. | Neoplasia | 2026 | 42217442 | PubTator, text mining | PubMed |
| Antioxidant properties of tauroursodeoxycholic acid towards free radicals revisited. | Photochem Photobiol | 2026 | 42084128 | PubTator, text mining | PubMed |
| Implementation of the FENIX assay to assess the anti-ferroptotic properties of test compounds. | Methods Cell Biol | 2026 | 41965288 | PubTator, text mining | PubMed |
| Fueling silence: Metabolic control of latent viral infection. | PLoS Pathog | 2026 | 41920818 | PubTator, text mining | PubMed |
| Veterinary Herpesviruses: Experimental Tools for Transcriptomics and Neuroscience. | Vet Sci | 2026 | 41893645 | PubTator, text mining | PubMed |
1 to 10 of 2,101
See all 2,101 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/23543
GET https://conductscience.org/api/genes/v1/23543/grants?page=2